Physician profile
Dennis J Sheehan
NPI 1205880101
$900,098.92
in general payments reported to CMS, 2019-2025
6 companies · $270K in 2025
The $270K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83K · 2020: $40K · 2021: $88K · 2022: $185K · 2023: $98K · 2024: $137K · 2025: $270K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $505K · Food and Beverage: $413 · Education: $8.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $504,886.20 |
| Food and Beverage | $412.69 |
| Education | $8.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $566,745.00 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Vital Connect, INC | $332,534.70 | 2022-2025 | Vitalpatch Rtm |
| Novo Nordisk INC | $578.78 | 2021-2024 | Wegovy, Ozempic |
| Sanofi-Aventis U.S. LLC | $108.23 | 2019 | |
| Portola Pharmaceuticals, LLC | $74.21 | 2020 | |
| Brainscope Company, INC. | $58.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,020,732.36 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Sheehan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.